Related Experiment Videos
Sarcoma and familial retinoblastoma
Celia S Chen1, Graeme Suthers, Jacqueline Carroll
1Department of Ophthalmology, Women's and Children's Hospital, Adelaide, South Australia, Australia. celiachen@bigpond.com
Clinical & Experimental Ophthalmology
|October 1, 2003
Summary
Genetic testing identified heritable RB1 mutations in two of three retinoblastoma patients without a family history but with a relative with sarcoma. This highlights the importance of genetic screening for heritable mutations.
Area of Science:
- Genetics
- Oncology
- Pediatrics
Background:
- Retinoblastoma, the most common childhood eye cancer, arises from RB1 gene mutations.
- While 10-25% of cases have a family history, some heritable mutations occur sporadically.
- Heritable RB1 mutations increase the risk of secondary sarcomas.
Observation:
- Three patients with prior retinoblastoma, no family history of it, but a first-degree relative with sarcoma were studied.
- Genomic DNA analysis of the RB1 gene was performed.
Findings:
- Heritable RB1 mutations were found in two of the three patients.
- Bayesian analysis indicated >90% probability of familial mutation in these two cases.
- One case had a low but potentially significant 16% chance of an unidentified familial RB1 mutation.
Implications:
- Genetic testing for heritable RB1 mutations is crucial for managing retinoblastoma patients.
- Identifying heritable mutations impacts risk assessment for non-ocular malignancies in families.
- Early detection and genetic counseling are vital for affected families.